Phillip C. C. Liu - Dept Appl Technol, Incyte Corp

基本信息

浏览量：29

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 92 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Activity of PARP1-selective Inhibitor SNV-001 in Models of HRD Cancers As Monotherapy and in Combination

Zhentian Li, Qipeng Fan, Mingming Gao,Jun Pan, Liangxing Wu, Wenqing Yao,Phillip C. Liu

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

Structural Insights Reveal Interplay Between LAG-3 Homodimerization, Ligand Binding, and Function

John L. Silberstein,Jasper Du,Kun-Wei Chan, Jessica A. Frank,Irimpan I. Mathews, Yong Bin Kim, Jia You,Qiao Lu,Jia Liu,Elliot A. Philips,Phillip Liu, Eric Rao, Daniel Fernandez, Grayson E. Rodriguez,Xiang-Peng Kong,Jun Wang,Jennifer R. Cochran

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAno. 12 (2024)

引用2浏览0WOS引用

Abstract 4562: Activity of PARP1-selective Inhibitor SNV-001 in Models of HRD Cancers As Monotherapy and in Combination

Zhentian Li,Qipeng Fan,Mingming Gao,Jun Pan,Liangxing Wu,Wenqing Yao,Phillip C. Liu

Cancer Researchno. 6_Supplement (2024): 4562-4562

引用0浏览0引用

Abstract 1956: Discovery of a Novel and Potent Mutant-Selective Inhibitor of PI3Kα

Mingming Gao,Chao Qi, Zhentian Li,Qipeng Fan, Liyang Wang, Fei Zhou, Lin You, Hewen Zheng, Yu Li,Liangxing Wu,Wenqing Yao,Phillip C. Liu

Cancer Researchno. 6_Supplement (2024): 1956-1956

引用0浏览0引用

Abstract 1648: Discovery of a Potent and Selective PARP1 Inhibitor and Trapper with Anti-Tumor Activities in HRD Tumors

Mingming Gao, Zhentian Li,Qipeng Fan,Jun Pan, Yu Bai, Hewen Zhang,Yu Li,Yongzhong Wu,Phillip C.C. Liu,Liangxing Wu,Wenqing Yao,Hui Wang

Cancer Researchno. 7_Supplement (2023): 1648-1648

引用0浏览0引用

Supplementary Data from Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Phillip C.C. Liu,Eian Caulder, Jun Li,Paul Waeltz,Alex Margulis,Richard Wynn,Mary Becker-Pasha,Yanlong Li,Erin Crowgey,Gregory Hollis,Patrick Haley,Richard B. Sparks,Andrew P. Combs, James D. Rodgers,Timothy C. Burn,Kris Vaddi,Jordan S. Fridman

crossref（2023）

引用0浏览0引用

Supplemental data from BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia

Haley E. Ramsey,Dalton Greenwood,Susu Zhang,Merrida Childress,Maria P. Arrate,Agnieszka E. Gorska,Londa Fuller, Yue Zhao,Kristy Stengel,Melissa A. Fischer,Matthew C. Stubbs,Phillip C.C. Liu,Kelli Boyd,Jeffrey C. Rathmell,Scott W. Hiebert,Michael R. Savona

crossref（2023）

引用0浏览0引用

An Engineered Interleukin‐11 Decoy Cytokine Inhibits Receptor Signaling and Proliferation in Lung Adenocarcinoma

Brianna J. McIntosh,Griffin G. Hartmann,Sean A. Yamada-Hunter,Phillip Liu, Camille F. Williams,Julien Sage,Jennifer R. Cochran

BIOENGINEERING & TRANSLATIONAL MEDICINEno. 6 (2023)

引用0浏览0WOS引用

Supplementary Data from Combined Inhibition of Janus Kinase 1/2 for the Treatment of JAK2V617F-Driven Neoplasms: Selective Effects on Mutant Cells and Improvements in Measures of Disease Severity

Phillip C.C. Liu,Eian Caulder,Jun Li,Paul Waeltz,Alex Margulis,Richard Wynn,Mary Becker-Pasha,Yanlong Li,Erin Crowgey,Gregory Hollis,Patrick Haley,Richard B. Sparks,Andrew P. Combs, James D. Rodgers,Timothy C. Burn,Kris Vaddi,Jordan S. Fridman

openalex（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn